MENU
REVS
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

REVS stock forecast, quote, news & analysis

The investment seeks investment results that, before fees and expenses, closely correspond to the performance of the Beta Advantage® Research Enhanced U... Show more

Category: #Large Value
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for REVS with price predictions
Nov 11, 2026

REVS saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for REVS moved out of overbought territory on November 03, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 68 similar instances where the indicator exited the overbought zone. In 49 of the 68 cases the stock moved lower. This puts the odds of a downward move at 72%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for REVS moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 50 similar instances where the indicator moved out of overbought territory. In 35 of the 50 cases, the stock moved lower in the following days. This puts the odds of a move lower at 70%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where REVS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

REVS broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on REVS as a result. In 68 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.

The Moving Average Convergence Divergence (MACD) for REVS just turned positive on November 09, 2026. Looking at past instances where REVS's MACD turned positive, the stock continued to rise in 44 of 48 cases over the following month. The odds of a continued upward trend are 90%.

REVS moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for REVS crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.

Following a +0.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where REVS advanced for three days, in 279 of 339 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

The Aroon Indicator entered an Uptrend today. In 320 of 381 cases where REVS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Apple (NASDAQ:AAPL), Microsoft Corp (NASDAQ:MSFT), Meta Platforms (NASDAQ:META), ABBVIE (NYSE:ABBV), Chevron Corp (NYSE:CVX), Cisco Systems (NASDAQ:CSCO), Bank of America Corp (NYSE:BAC), Amgen (NASDAQ:AMGN), Dell Technologies (NYSE:DELL), Gilead Sciences (NASDAQ:GILD).

Industry description

The investment seeks investment results that, before fees and expenses, closely correspond to the performance of the Beta Advantage® Research Enhanced U.S. Value Index. The fund invests at least 80% of its assets in the securities of the index. The index reflects a rules-based strategic beta approach to investing in the companies that comprise the Russell 1000® Value Index, designed to achieve stronger total return when compared to the Russell 1000® Value Index, which is a broad measure of the performance of U.S. large- and mid-cap value companies.

Market Cap

The average market capitalization across the Columbia Research Enhanced Value ETF (REVS) ETF is 57.47B. The market cap for tickers in the group ranges from 1.08B to 5T. AAPL holds the highest valuation in this group at 5T. The lowest valued company is MPT at 1.08B.

High and low price notable news

The average weekly price growth across all stocks in the Columbia Research Enhanced Value ETF (REVS) ETF was -1%. For the same ETF, the average monthly price growth was 3%, and the average quarterly price growth was 13%. VNT experienced the highest price growth at 16%, while IONS experienced the biggest fall at -29%.

Volume

The average weekly volume growth across all stocks in the Columbia Research Enhanced Value ETF (REVS) ETF was -46%. For the same stocks of the ETF, the average monthly volume growth was -5% and the average quarterly volume growth was -37%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 52
Price Growth Rating: 43
SMR Rating: 53
Profit Risk Rating: 60
Seasonality Score: 15 (-100 ... +100)